Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute dynamic registry.
about
Major adverse cardiac events and mortality in chronic obstructive pulmonary disease following percutaneous coronary intervention: a systematic review and meta-analysis.Disparities experienced by Aboriginal compared to non-Aboriginal metropolitan Western Australians in receiving coronary angiography following acute ischaemic heart disease: the impact of age and comorbiditiesCoronary artery calcification, epicardial fat burden, and cardiovascular events in chronic obstructive pulmonary diseaseTime trends in coronary revascularization procedures among people with COPD: analysis of the Spanish national hospital discharge data (2001-2011)Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study.Coronary artery disease is under-diagnosed and under-treated in advanced lung disease.Impact of Chronic Obstructive Pulmonary Disease on Long-Term Outcome in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice.Vascular dysfunction in chronic obstructive pulmonary disease: current evidence and perspectives.Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management.Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care.Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention.The role of beta-blockers in the management of chronic obstructive pulmonary disease.Coronary lesions in patients with COPD (Global Initiative for Obstructive Lung Disease stages I–III) and suspected or confirmed coronary arterial disease.
P2860
Q33913180-43BF58D6-7E18-4AE0-A2D2-23641CDDBC85Q34396298-E2C13672-4A85-4B77-A4E9-80A65D37A99FQ35641810-4643E6B0-3A3F-41AD-B04C-AB274619A6ADQ35834340-7E3E071A-6873-446A-8488-A655A3CE780DQ35871744-75403C16-5861-4884-9171-AC08275A60C2Q37066051-4A9C7C52-DE9C-40AE-8FBA-BABF6696B85FQ37500727-E2488CBB-5382-4817-A1F2-C14D2C55F0C5Q37964807-3B6A7D79-B556-4D37-9101-E619F2C1C1CEQ37979248-6DBABC64-881F-4FAF-9E22-B3B9B3F49870Q38342003-09F390F0-AC99-431F-8563-DD659CF6569FQ38944856-C8871BE8-0605-4873-9941-AF9B2A6D94C0Q44939547-5D994113-5117-4F40-9FE9-C25DDDAF30D8Q47676572-4B2C3FE2-C71C-4776-A5B8-7A6FC59C0A2BQ55428223-9D23BD6B-D60D-4FEC-B916-494C80FD27B6
P2860
Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute dynamic registry.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Increased adverse events after ...... od Institute dynamic registry.
@ast
Increased adverse events after ...... od Institute dynamic registry.
@en
type
label
Increased adverse events after ...... od Institute dynamic registry.
@ast
Increased adverse events after ...... od Institute dynamic registry.
@en
prefLabel
Increased adverse events after ...... od Institute dynamic registry.
@ast
Increased adverse events after ...... od Institute dynamic registry.
@en
P2093
P2860
P356
P1433
P1476
Increased adverse events after ...... od Institute dynamic registry.
@en
P2093
Elizabeth M Holper
Faith Selzer
Jonathan R Enriquez
Oscar Marroquin
Shailja V Parikh
Suresh Mulukutla
Vankeepuram Srinivas
P2860
P304
P356
10.1378/CHEST.10-2644
P407
P577
2011-04-28T00:00:00Z